Cargando…

Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy

Cancer vaccination and immunotherapy revolutionised the treatment of cancer, a result of decades of research into the immune system in health and disease. However, despite recent breakthroughs in treating otherwise terminal cancer, only a minority of patients respond to cancer immunotherapy and some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Peter Lawrence, Piadel, Katarzyna, Dalgleish, Angus George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708201/ https://www.ncbi.nlm.nih.gov/pubmed/34960140 http://dx.doi.org/10.3390/vaccines9121392

Ejemplares similares

Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2
por: Piadel, Katarzyna, et al.
Publicado: (2022)

Developments in HIV-1 immunotherapy and therapeutic vaccination
por: Smith, Peter Lawrence, et al.
Publicado: (2014)

The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12–13, 2017, Royal Society, London, UK
por: Dalgleish, Angus G
Publicado: (2018)

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
por: Ridgley, Laura A., et al.
Publicado: (2023)

Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
por: Galustian, Christine, et al.
Publicado: (2022)

Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
por: Fowler, Daniel W., et al.
Publicado: (2011)

Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2022)

The failure of radical treatments to cure cancer: can less deliver more?
por: Dalgleish, Angus G., et al.
Publicado: (2018)

Detection of T Cell Cytokine Production as a Tool for Monitoring Immunotherapy
por: John, J., et al.
Publicado: (2000)

Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
por: Fernández-Delgado, Irene, et al.
Publicado: (2020)

Immunotherapy and Immune Evasion in Prostate Cancer
por: Thakur, Archana, et al.
Publicado: (2013)

T-regulatory cell modulation: the future of cancer immunotherapy?
por: Nizar, S, et al.
Publicado: (2009)

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
por: Weir, Genevieve M., et al.
Publicado: (2011)

Cancer vaccines
por: Dalgleish, A G
Publicado: (2000)

Autophagy-associated immune responses and cancer immunotherapy
por: Pan, Hongming, et al.
Publicado: (2016)

Tumor immune response and immunotherapy in gastric cancer
por: Kwak, Yoonjin, et al.
Publicado: (2020)

Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy
por: Lauwerys, Louis, et al.
Publicado: (2022)

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients
por: Dalgleish, Angus G., et al.
Publicado: (2022)

Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
por: Sørensen, Birger, et al.
Publicado: (2020)

Leishmania Immunity: Advancing Immunotherapy and Vaccine Development
por: Ikeogu, Nnamdi M., et al.
Publicado: (2020)

Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma
por: Rhee, John Y., et al.
Publicado: (2023)

Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
por: Keenan, Bridget P., et al.
Publicado: (2019)

Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy
por: Li, Bo, et al.
Publicado: (2021)

Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
por: Ostios-Garcia, Lorena, et al.
Publicado: (2021)

Targeting the interleukin-17 immune axis for cancer immunotherapy
por: Vitiello, Gerardo A., et al.
Publicado: (2020)

DNA vaccine for cancer immunotherapy
por: Yang, Benjamin, et al.
Publicado: (2015)

Immunotherapies: Exploiting the Immune System for Cancer Treatment
por: Koury, Jeffrey, et al.
Publicado: (2018)

Immune Aging and Immunotherapy in Cancer
por: Kaiser, Melanie, et al.
Publicado: (2021)

Dexosomes as a cell-free vaccine for cancer immunotherapy
por: Nikfarjam, Sepideh, et al.
Publicado: (2020)

Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022)

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
por: Bowers, Jacob S., et al.
Publicado: (2019)

Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018)

Exercise and the immune system: taking steps to improve responses to cancer immunotherapy
por: Gustafson, Michael P, et al.
Publicado: (2021)

Quantity of Immune Cells Predict Response to Immunotherapy in Cancer
por: Salgado, Roberto, et al.
Publicado: (2021)

A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers
por: Nahas, George R., et al.
Publicado: (2015)

Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
por: Ellmark, Peter, et al.
Publicado: (2016)

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
por: Sittig, Simone P., et al.
Publicado: (2015)

Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions
por: Zeng, Guoming, et al.
Publicado: (2020)

Therapeutic cancer vaccines and combination immunotherapies involving vaccination
por: Nguyen, Trang, et al.
Publicado: (2014)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gvf30tuit98fgqcgio504e9jm5